Other Deals - Listed Firms
Promoters pare 10% stake in diagnostic chain Thyrocare in Rs.986-Cr block deal
BSE Announcement Business Standard Thyrocare
Docon Technologies, a promoter of the Mumbai-based healthcare diagnostic firm Thyrocare Technologies , sold a 9.9% stake for INR 986 crore. Following the transaction, Docon’s holding declined from 60.92% to 51.02%. It continues to remain the promoter and holding company of Thyrocare.Established in 1996, Thyrocare operates diagnostic laboratories providing preventive healthcare and diagnostic testing services. The company offers a range of routine and specialised diagnostic tests through its laboratory and collection network.
In June-21, Docon Technologies Pvt Ltd, a 100% subsidiary of API Holdings - the parent company of pharma e-tail service PharmEasy - had acquired a 66.14% stake in Thyrocare Technologies from its founder A Velumani for INR 4,546 crore.For FY26, Thyrocare Technologies had reported about INR 774 Cr in Operating Income and about INR 149 Cr in PAT.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
